Use of selective-serotonin reuptake inhibitors and platelet aggregation inhibitors among individuals with co-occurring atherosclerotic cardiovascular disease and depression or anxiety

OBJECTIVE: Medications commonly used to treat heart disease, anxiety, and depression can interact resulting in an increased risk of bleeding, warranting a cautious approach in medical decision making. This retrospective, descriptive study examined the prevalence and the factors associated with the u...

Descripción completa

Detalles Bibliográficos
Autores principales: Thornton, J Douglas, Agarwal, Parul, Sambamoorthi, Usha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354183/
https://www.ncbi.nlm.nih.gov/pubmed/28348738
http://dx.doi.org/10.1177/2050312116682255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354183/
https://www.ncbi.nlm.nih.gov/pubmed/28348738
http://dx.doi.org/10.1177/2050312116682255

Ejemplares similares